219 related articles for article (PubMed ID: 3056253)
1. Endogenous active efflux of norfloxacin in susceptible Escherichia coli.
Cohen SP; Hooper DC; Wolfson JS; Souza KS; McMurry LM; Levy SB
Antimicrob Agents Chemother; 1988 Aug; 32(8):1187-91. PubMed ID: 3056253
[TBL] [Abstract][Full Text] [Related]
2. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
Cohen SP; McMurry LM; Hooper DC; Wolfson JS; Levy SB
Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
[TBL] [Abstract][Full Text] [Related]
3. OmpF channel permeability of quinolones and their comparison with beta-lactams.
Sawai T; Yamaguchi A; Saiki A; Hoshino K
FEMS Microbiol Lett; 1992 Aug; 74(1):105-8. PubMed ID: 1516804
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
Hooper DC; Wolfson JS; Souza KS; Ng EY; McHugh GL; Swartz MN
Antimicrob Agents Chemother; 1989 Mar; 33(3):283-90. PubMed ID: 2658782
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of ciprofloxacin and lomefloxacinin fluoroquinolone-resistant strains of Escherichia coli.
Xia P; Feng P; Zhong L; Lu X; Lei B
Chin Med J (Engl); 2002 Jan; 115(1):31-5. PubMed ID: 11930654
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of ofloxacin and tosufloxacin in fluoroquinolone-resistant E coli.
Xia PY; Feng P; Zhong L; Lv XJ; Lei BJ
Acta Pharmacol Sin; 2001 Mar; 22(3):210-4. PubMed ID: 11742566
[TBL] [Abstract][Full Text] [Related]
7. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.
Ng EY; Trucksis M; Hooper DC
Antimicrob Agents Chemother; 1994 Jun; 38(6):1345-55. PubMed ID: 8092836
[TBL] [Abstract][Full Text] [Related]
8. The comparative pharmacokinetics and tissue penetration of four quinolones including intravenously administered enoxacin.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
Infection; 1986; 14 Suppl 3():S196-202. PubMed ID: 3463542
[TBL] [Abstract][Full Text] [Related]
9. Membrane permeability of Pseudomonas aeruginosa to 4-quinolones.
Kubesch P; Wehsling M; Tümmler B
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jun; 265(1-2):197-202. PubMed ID: 3118593
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12.
Hirai K; Aoyama H; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Aug; 30(2):248-53. PubMed ID: 3532944
[TBL] [Abstract][Full Text] [Related]
11. [Accumulation and efflux of quinolones by clinical isolates of Stenotrophomonas maltophilia].
Sánchez P; Alonso A; Campanario E; Alós I; Martíinez JL
Rev Esp Quimioter; 2000 Jun; 13(2):176-81. PubMed ID: 10918091
[TBL] [Abstract][Full Text] [Related]
12. Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.
Liu J; Takiff HE; Nikaido H
J Bacteriol; 1996 Jul; 178(13):3791-5. PubMed ID: 8682782
[TBL] [Abstract][Full Text] [Related]
13. A comparison of methods used for measuring the accumulation of quinolones by Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus.
Mortimer PG; Piddock LJ
J Antimicrob Chemother; 1991 Nov; 28(5):639-53. PubMed ID: 1663928
[TBL] [Abstract][Full Text] [Related]
14. [Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].
Miró E; Vergés C; García I; Mirelis B; Navarro F; Coll P; Prats G; Martínez-Martínez L
Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):204-11. PubMed ID: 15056435
[TBL] [Abstract][Full Text] [Related]
15. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli.
Morita Y; Kodama K; Shiota S; Mine T; Kataoka A; Mizushima T; Tsuchiya T
Antimicrob Agents Chemother; 1998 Jul; 42(7):1778-82. PubMed ID: 9661020
[TBL] [Abstract][Full Text] [Related]
16. The comparative pharmacokinetics of five quinolones.
Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
[TBL] [Abstract][Full Text] [Related]
17. Differences in susceptibility to quinolones of outer membrane mutants of Salmonella typhimurium and Escherichia coli.
Hirai K; Aoyama H; Irikura T; Iyobe S; Mitsuhashi S
Antimicrob Agents Chemother; 1986 Mar; 29(3):535-8. PubMed ID: 3521490
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in the development of resistance to fluoroquinolones in Escherichia coli isolates.
Tavío MM; Vila J; Ruiz J; Ruiz J; Martín-Sánchez AM; Jiménez de Anta MT
J Antimicrob Chemother; 1999 Dec; 44(6):735-42. PubMed ID: 10590273
[TBL] [Abstract][Full Text] [Related]
19. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
Bassey CM; Baltch AL; Smith RP
J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
[TBL] [Abstract][Full Text] [Related]
20. Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains.
Tavío MM; Vila J; Perilli M; Casañas LT; Maciá L; Amicosante G; Jiménez de Anta MT
J Med Microbiol; 2004 Nov; 53(Pt 11):1119-1122. PubMed ID: 15496390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
